Iovance Biotherapeutics, Inc. IOVA Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s income tax?
- Iovance Biotherapeutics, Inc. (IOVA) reported income tax of -$665K in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s income tax changed year-over-year?
- Iovance Biotherapeutics, Inc.'s income tax increased by 63.8% year-over-year, from -$1.84M to -$665K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.